Humedix, a subsidiary of Huons Group, has expanded its aesthetics portfolio by securing the domestic distribution rights for 'Riddle Booster'.

Humedix signed an exclusive supply contract for 'Riddle Booster' with Above Therapeutics on the 8th, and Minjong Kang, CEO of Humedix (left), and Byungkuk Park, CEO of Above Therapeutics (right), are taking a commemorative photo. Photo by Humedix

Humedix signed an exclusive supply contract for 'Riddle Booster' with Above Therapeutics on the 8th, and Minjong Kang, CEO of Humedix (left), and Byungkuk Park, CEO of Above Therapeutics (right), are taking a commemorative photo. Photo by Humedix

View original image

On August 11, Humedix announced that it recently signed an exclusive domestic sales agreement with Above Therapeutics for 'Riddle Booster PN/EX (REEDLE BOOSTER PN/EX)'.


'Riddle Booster', jointly developed by VT and Above Therapeutics, is a product designed for use in clinics and hospitals, based on VT Cosmetics' (VT) 'Riddle Shot', which has recently gained popularity in both domestic and international beauty markets. Compared to injectable skin booster procedures, it offers less pain and a shorter recovery period, enabling a quick return to daily activities after the procedure and providing immediate skin revitalization effects.


Riddle Booster utilizes the patented 'RED REEDLE™' channeling technology to create micro-channels on the skin surface, facilitating the deep delivery of active ingredients into the dermis layer.


With this agreement, Humedix has secured exclusive domestic distribution rights for both 'Riddle Booster EX', which contains next-generation plant-derived exosomes as its active ingredient, and 'Riddle Booster PN', which contains low-molecular-weight polynucleotides (PN) as its active ingredient. The company plans to expand its distribution and procedure market targeting dermatology and plastic surgery clinics specializing in aesthetics.


Byungkuk Park, CEO of Above Therapeutics, stated, "Through our collaboration with Humedix, which has established a strong presence in the domestic aesthetics market, we plan to promote the technological excellence of Riddle Booster and maximize its brand value."



Minjong Kang, CEO of Humedix, said, "Riddle Booster is a professional product that originated from the recognition and consumer demand for Riddle Shot, which has already achieved great success in the K-beauty market. By adding a differentiated epidermal-targeted procedure solution to our existing product lineup, we have secured a wider range of options."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing